Inactivation of SARS-CoV-2 Laboratory Specimens

The burden on diagnostic and research laboratories to provide reliable inactivation for biological specimens to allow for safe downstream processing is high during the coronavirus disease 2019 (COVID-19) pandemic. We provide safety data regarding commonly used chemical and physical inactivation proc...

Descripción completa

Detalles Bibliográficos
Autores principales: Haddock, Elaine, Feldmann, Friederike, Shupert, W. Lesley, Feldmann, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176508/
https://www.ncbi.nlm.nih.gov/pubmed/33878029
http://dx.doi.org/10.4269/ajtmh.21-0229
_version_ 1783703269481119744
author Haddock, Elaine
Feldmann, Friederike
Shupert, W. Lesley
Feldmann, Heinz
author_facet Haddock, Elaine
Feldmann, Friederike
Shupert, W. Lesley
Feldmann, Heinz
author_sort Haddock, Elaine
collection PubMed
description The burden on diagnostic and research laboratories to provide reliable inactivation for biological specimens to allow for safe downstream processing is high during the coronavirus disease 2019 (COVID-19) pandemic. We provide safety data regarding commonly used chemical and physical inactivation procedures that verify their effectiveness against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
format Online
Article
Text
id pubmed-8176508
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The American Society of Tropical Medicine and Hygiene
record_format MEDLINE/PubMed
spelling pubmed-81765082021-06-07 Inactivation of SARS-CoV-2 Laboratory Specimens Haddock, Elaine Feldmann, Friederike Shupert, W. Lesley Feldmann, Heinz Am J Trop Med Hyg Articles The burden on diagnostic and research laboratories to provide reliable inactivation for biological specimens to allow for safe downstream processing is high during the coronavirus disease 2019 (COVID-19) pandemic. We provide safety data regarding commonly used chemical and physical inactivation procedures that verify their effectiveness against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The American Society of Tropical Medicine and Hygiene 2021-06 2021-04-20 /pmc/articles/PMC8176508/ /pubmed/33878029 http://dx.doi.org/10.4269/ajtmh.21-0229 Text en © The American Society of Tropical Medicine and Hygiene https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Articles
Haddock, Elaine
Feldmann, Friederike
Shupert, W. Lesley
Feldmann, Heinz
Inactivation of SARS-CoV-2 Laboratory Specimens
title Inactivation of SARS-CoV-2 Laboratory Specimens
title_full Inactivation of SARS-CoV-2 Laboratory Specimens
title_fullStr Inactivation of SARS-CoV-2 Laboratory Specimens
title_full_unstemmed Inactivation of SARS-CoV-2 Laboratory Specimens
title_short Inactivation of SARS-CoV-2 Laboratory Specimens
title_sort inactivation of sars-cov-2 laboratory specimens
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176508/
https://www.ncbi.nlm.nih.gov/pubmed/33878029
http://dx.doi.org/10.4269/ajtmh.21-0229
work_keys_str_mv AT haddockelaine inactivationofsarscov2laboratoryspecimens
AT feldmannfriederike inactivationofsarscov2laboratoryspecimens
AT shupertwlesley inactivationofsarscov2laboratoryspecimens
AT feldmannheinz inactivationofsarscov2laboratoryspecimens

Ejemplares similares